Charles P, Mosekilde L, Jensen F T
Eur J Clin Invest. 1986 Aug;16(4):277-83. doi: 10.1111/j.1365-2362.1986.tb01342.x.
Combined 47Calcium kinetic and calcium balance studies with correction for dermal calcium loss were performed in thirteen patients with primary hyperparathyroidism (PHP), in whom serum bone-Gla-protein (S-BGP) was measured, and in ten matched controls. Dietary calcium was normal in PHP but both net (7.9 +/- 1.4 mmol Ca day-1 in PHP v. 3.5 +/- 0.9 mmol Ca day-1 in normals (mean +/- SE] and true (11.1 +/- 1.6 v. 6.8 +/- 0.9 mmol Ca day-1) intestinal absorbed calcium were enhanced (P less than 0.05). The renal calcium excretion (10.9 +/- 0.8 v. 5.1 +/- 0.4 mmol Ca day-1, P less than 0.001) and the dermal calcium loss (2.5 +/- 0.3 v. 1.5 +/- 0.1 mmol Ca day-1, P less than 0.02) were increased in PHP. Both patients and controls were in a negative calcium balance (P less than 0.01 and P less than 0.001, respectively) without any difference between the groups (P greater than 0.10). Mineralization (12.0 +/- 1.7 v. 4.8 +/- 0.8 mmol Ca day-1, P less than 0.02) and resorption rates (17.6 +/- 2.5 v. 7.9 +/- 0.6 mmol Ca day-1, P less than 0.02) were increased in PHP and S-BGP correlated positively to both variables (r = 0.64, P less than 0.05 and r = 0.62, P less than 0.05, respectively). Serum immunoreactive parathyroid hormone correlated positively to serum calcium (r = 0.69, P less than 0.01) but not to the calcium kinetic data.
对13例原发性甲状旁腺功能亢进症(PHP)患者、测定了血清骨钙素(S-BGP)的13例PHP患者以及10例匹配的对照者进行了联合47钙动力学和钙平衡研究,并校正了皮肤钙流失。PHP患者的饮食钙正常,但净(PHP组为7.9±1.4 mmol钙/天,正常组为3.5±0.9 mmol钙/天[均值±标准误])和真实(11.1±1.6对6.8±0.9 mmol钙/天)肠道吸收钙均增加(P<0.05)。PHP患者的肾钙排泄(10.9±0.8对5.1±0.4 mmol钙/天,P<0.001)和皮肤钙流失(2.5±0.3对1.5±0.1 mmol钙/天,P<0.02)增加。患者和对照者均处于负钙平衡(分别为P<0.01和P<0.001),两组之间无差异(P>0.10)。PHP患者的矿化率(12.0±1.7对4.8±0.8 mmol钙/天,P<0.02)和吸收率(17.6±2.5对7.9±0.6 mmol钙/天,P<0.02)增加,且S-BGP与这两个变量均呈正相关(r=0.64,P<0.05和r=0.62,P<0.05)。血清免疫反应性甲状旁腺激素与血清钙呈正相关(r=0.69,P<0.01),但与钙动力学数据无关。